Item 1.01. Entry Into a Material Definitive Agreement.
On May 3, 2023, MeiraGTx Holdings plc (the “Company”) entered into a Securities Purchase Agreement with certain accredited investors listed on Schedule 1 thereto (the “Investors”), pursuant to which the Company, in a private placement, agreed to issue and sell to the Investors an aggregate of 10,773,913 ordinary shares, nominal value $0.00003881 per share, at a purchase price of $5.75 per share (the “Shares”), for gross proceeds of $61,949,999.75 before deducting private placement expenses (the “Private Placement”). The closing of the Private Placement occurred on May 5, 2023.
In connection with the Private Placement, the Company also entered into a Registration Rights Agreement, dated May 5, 2023 (the “Registration Rights Agreement”) with the Investors. Pursuant to the terms of the Registration Rights Agreement, the Company is obligated to prepare and file with the Securities and Exchange Commission (the “SEC”) a registration statement to register for resale the Shares on or prior to August 3, 2023.
Perceptive Life Sciences Master Fund Ltd. (“Perceptive Master Fund”), one of the Investors in the Private Placement, and its affiliates own, in the aggregate, more than 10% of the Company’s outstanding shares, and an affiliate of Perceptive Master Fund holds a $75 million note issued by the Company. Additionally, Ellen Hukkelhoven, Ph.D., a member of the Company’s Board of Directors, is Head of Biotechnology Investments of Perceptive Advisors, LLC, an affiliate of Perceptive Master Fund.
Item 3.02 Unregistered Sales of Equity Securities.
Pursuant to the Private Placement described in Item 1.01 of this Current Report on Form 8-K, which description is incorporated by reference into this Item 3.02 in its entirety, on May 5, 2023, the Company sold the Shares to “accredited investors,” as that term is defined in the Securities Act of 1933, as amended (the “Securities Act”), in reliance on the exemption from registration afforded by Section 4(a)(2) of the Securities Act and corresponding provisions of state securities or “blue sky” laws. Each of the Investors represented that it was acquiring the Shares for investment only and not with a view towards, or for resale in connection with, the public sale or distribution thereof. Accordingly, the Shares have not been registered under the Securities Act and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act and any applicable state securities laws.
Neither this Current Report on Form 8-K nor any exhibit attached hereto is an offer to sell or the solicitation of an offer to buy ordinary shares or other securities of the Company.
